Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Double enzyme method for preparing medicinal dextran with controllable molecular weight

A technology of dextran and dextranase, which is applied in the field of medicinal dextran, can solve the problems of low yield, unfavorable industrial production, unfavorable product separation and purification, and achieve low cost and increase product yield.

Inactive Publication Date: 2012-09-19
HEFEI UNIV OF TECH
View PDF2 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, foreign scholars have directly used bacterial strains producing dextran sucrase and dextranase to prepare medicinal dextran directly. Conducive to industrial production
In addition, some scholars use dextran sucrase and dextranase double enzymes to prepare medicinal anhydride, but due to the low yield (36%), it is not conducive to industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] (1) Synthesis of polymer dextran by dextran sucrase includes the following two steps A and B:

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Weight average molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to a double enzyme method for preparing medicinal dextran with controllable molecular weight. The medicinal dextran comprises dextran 70, dextran 40 and dextran 20. The preparation steps of the medicinal dextran comprise two steps of: firstly, synthesizing high molecular dextran: firstly, preparing the high molecular dextran by catalyzing sucrose by adopting dextran, wherein the conversion rate of the sucrose converted into the dextran reaches over 95 percent; secondly, controllably degrading the high molecular dextran: carrying out catalytic degradation on the high molecular dextran into the medicinal dextran as the medicinal dextran by adopting dextranase with high enzyme activity and realizing the controllable degradation of the dextran; and after the reaction is ended, removing impure protein in the products by adopting a simple filtering method and obtaining dextrans with different molecular weights by adopting graded ethanol precipitation. The double enzyme method has the advantages of greenness, environment friendliness, low cost, simplicity and convenience; and in addition, according to the double enzyme method, the yield of products can be greatly improved and the medicinal dextran with high quality is obtained.

Description

technical field [0001] The invention relates to the fields of biopharmaceuticals and enzyme engineering, in particular to a process for jointly preparing medicinal dextran with controllable molecular weight by using dextran sucrase and dextranase. Background technique [0002] Dextran (Dextran) is a polymer formed by the dehydration of several glucans, which is mainly connected by glucose α-1, 6 glycosidic bonds. Dextran sucrase (Dextransucrase; E.C.2.4) produced by Leuconstoc mesenteriodes .1.5) The synthesized dextran contains 95% α-1, 6 glucosidic bonds, and contains a small amount of branched structures of other glycosidic bonds. Because of its many advantages such as safety and non-toxicity, it has been widely used in many fields such as medicine, industry and food. Polymer dextran can be used as a drug carrier, as well as a commonly used gel chromatography filler. Dextran 70, Dextran 40, and Dextran 20 are commonly used clinically, and are mainly used as plasma subst...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12P19/18C12P19/16
Inventor 张洪斌甘微苇吴定涛胡雪芹
Owner HEFEI UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products